EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

MARK2 CORPORATION (M2C) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of MARK2 CORPORATION CZK 103, price CZK 127, upside -18.7%, quality 43 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Industrials · CZ · ISIN CZ1008000823

MC Some data Sep 24, 2026

MARK2 CORPORATION

M2C · PR

Weak valuationQuality is weak on top of the rich price.

!Fair value 103.29 CZK · Overvalued (−19%)
!Quality 43/100
!Expensive Growth (revenue 3y +13.2 %/yr)
!Thin margins · 0.4% net margin (TTM)
!Low debt · negative free cash flow
!Trails peers (4/12)
!Narrow moat 29/100
!Evidence only medium, so the estimate is less certain
!Weak on valuation: 8 out of 100
!Weak on past: 11 out of 100
Watch MARK2 CORPORATION for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

302.00 CZK 127.00 CZK Fair Value 103.29 CZK Jun 2025 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

15‑month range 127.00 CZK – 302.00 CZK · fair‑value band 77.47 CZK – 129.11 CZK · the 127.00 CZK price screens above the 103.29 CZK fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow MARK2 in your weekly email

Every Wednesday you see whether MARK2 is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Mark2 Corporation Investment SE provides integrated facility management services in Europe.

Show more

Mark2 Corporation Investment SE provides integrated facility management services in Europe. The company engages in the provision of property and persons physical security services; planning and implementation of maintenance and repairs, as well as preventive and predictive maintenance; cleaning of administrative buildings, shopping centers, and industrial areas; and maintenance of lawns, gardens, terraces, and plant care in shopping centers or office buildings. It also provides energy consumption management services; construction management services, such as interior remodeling, renovations, and equipment replacements; and smart building management technologies for building administration and security. The company was founded in 1992 and is based in Prague, Czech Republic.

Stock analysis

MARK2 CORPORATION (M2C) currently trades at 127.00 CZK, while our model-based Fair Value estimate is 103.29 CZK, implying the stock looks roughly 23.0% overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of 141.07 CZK per share, and 7 of the 14 models we run sit above the 127.00 CZK price.

Bear case: the Earnings-Based group reads lowest at 39.99 CZK, and 7 of the 14 models stay below the price. Evidence for this calculation is medium.

Scenario range: 77.47 CZK (bear) to 129.11 CZK (bull), the price of 127.00 CZK sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 43/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

MARK2 CORPORATION reported revenue of 4.6B CZK in FY2025 versus 3.2B CZK in FY2022, a compound +13.2%/yr. Reported net income was 18.8M CZK in FY2025, compounding −25.3%/yr from FY2022.

Key figures

Market cap 726M CZK (≈ $33.8M) · P/E ratio 25.8 · P/S ratio 0.11 · EPS (TTM) 4.92 CZK · Net margin 0.4% · Return on equity 2.8% · Return on assets (EBIT) 9.6% · Operating margin 1.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (medium confidence).

What moves the price

The share trades about 55% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 0% fair-value upside, at −19%, M2C screens richer than that median.

Fair Value models

Bear 77.47 CZK Fair Value 103.29 CZK Bull 129.11 CZK
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (3.61 CZK per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV 223.80 CZK 254.72 CZK 281.39 CZK 71
ROIC Compounder 228.19 CZK 283.63 CZK 356.82 CZK 69
Residual Income 147.19 CZK 139.76 CZK 110.30 CZK 68
All 14 models by family
Earnings-Based
Graham-Dodd 33.45 CZK 119.08 CZK 160.35 CZK 61
Lynch FV 27.99 CZK 39.99 CZK 51.98 CZK 58
PEG = 1.0 27.99 CZK 39.99 CZK 51.98 CZK 55
EPV 223.80 CZK 254.72 CZK 281.39 CZK 71
Multiples
P/E Multiple 77.47 CZK 103.29 CZK 129.11 CZK 63
P/S Multiple 62.71 CZK 83.62 CZK 104.52 CZK 58
P/B Multiple 62.71 CZK 83.62 CZK 104.52 CZK 55
EV/EBIT 375.61 CZK 491.48 CZK 607.34 CZK 66
EV/EBITDA 411.78 CZK 539.71 CZK 667.63 CZK 67
EV/Revenue 276.10 CZK 382.42 CZK 488.75 CZK 54
Asset-Based
NCAV (Graham) 105.28 CZK 141.07 CZK 210.55 CZK 54
Economic Profit
Residual Income 147.19 CZK 139.76 CZK 110.30 CZK 68
ROIC Compounder 228.19 CZK 283.63 CZK 356.82 CZK 69
Growth Earnings
Growth-Adj P/E 53.78 CZK 76.83 CZK 99.87 CZK 65

Open the full fair value analysis →

Notify me when M2C reaches fair value

Put M2C on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 43/100

Of which business quality 46 · Market factors (momentum, volatility) 22

Profitability 52
Margins and returns on capital today
Quality Growth 14
Are margins and returns improving?
Cashflow 4
Earnings quality: real cash, not paper profit
Fin. Strength 80
Balance sheet, leverage, solvency risk
Investment 42
Disciplined investing over empire-building
Low Volatility 68
Calm price path (market factor)
Momentum 3
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 56/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+2.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.2%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+1.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.3%
Dividend (yield on the price)0.0%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 2%

M2C screens 23% overvalued. Compare with Cintas Corporation →

Compare MARK2 CORPORATION with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 249 stocks

Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 43 · Bottom 25%
Fair Value upside −24% · Below median
Profitability
Return on equity (TTM) 3% · Below median
Return on assets 3% · Below median
Net margin (TTM) 0% · Below median
Operating margin (TTM) 2% · Below median
Growth and dividend
Revenue growth 0% · Below median
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/E (TTM) 25.8× · Pricier than median
P/B 0.90× · Cheaper than median
P/S (TTM) 0.16× · Cheapest 25%
EV/EBITDA 5.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)8 · sector 46
FUTURE (revenue growth)0 · sector 27
PAST (return on equity)11 · sector 36
HEALTH (low debt)98 · sector 90
DIVIDEND (yield)0 · sector 54

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Cintas Corporation CTAS $198.80 $181.30 −9%
Thomson Reuters Corporation TRI $95.66 $70.26 −27%
Copart, Inc CPRT $28.80 $32.23 +12%
Global Payments Inc GPN $84.78 $85.85 +1%
RB Global, Inc RBA C$117.34 C$129.07 +10%
UL Solutions Inc ULS $66.65 $33.62 −50%
Brambles Limited BXB A$18.73 A$18.66 +0%
Wolters Kluwer N.V WKL €66.82 €97.78 +46%
Aramark ARMK $56.59 $23.15 −59%
Rentokil Initial plc RTO $21.37 $19.63 −8%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

MARK2 CORPORATION · Fair Value
103.29 CZK −23%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "MARK2 CORPORATION Fair Value". https://www.fairvalue-calculator.com/stock/M2C

Frequently asked questions

Is MARK2 CORPORATION (M2C) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 103.29 CZK versus a price of 127.00 CZK, about −19% upside (overvalued).
What is the fair value of M2C?
Our model-based fair value for MARK2 CORPORATION is 103.29 CZK (as of Sep 24, 2026), built from audited fundamentals. The current price: 127.00 CZK.
What is the quality score of M2C?
MARK2 CORPORATION has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for MARK2 CORPORATION (M2C)?
Our model-based price target is the fair value of 103.29 CZK (as of Sep 24, 2026) from 14 valuation models. Cautious scenario 77.47 CZK, optimistic scenario 129.11 CZK. It is a calculation from audited fundamentals, not an analyst target.
What is the MARK2 CORPORATION stock forecast for 2026?
Our models put fair value at 103.29 CZK, about −19% upside versus a price of 127.00 CZK (overvalued). Cautious scenario 77.47 CZK, optimistic scenario 129.11 CZK. The calculation is refreshed regularly with new filings.
What is the revenue of MARK2 CORPORATION (M2C)?
MARK2 CORPORATION reported trailing-twelve-month revenue of about 4.6B CZK (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of MARK2 CORPORATION (M2C)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For MARK2 CORPORATION it is 103.29 CZK per share (as of Sep 24, 2026), against a price of 127.00 CZK. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is MARK2 CORPORATION stock overvalued or undervalued in 2026?
As of Sep 24, 2026, M2C trades above its calculated fair value: price 127.00 CZK, fair value 103.29 CZK, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of M2C?
No. The price is what the market pays today (127.00 CZK); the fair value is what the company's own numbers justify (103.29 CZK). For MARK2 CORPORATION the two are 23.71 CZK per share apart. That gap is exactly why we show both numbers side by side.
How much is MARK2 CORPORATION worth?
The market values MARK2 CORPORATION at about 726M CZK (market capitalisation, as of Sep 24, 2026). Per share that is 127.00 CZK; our models calculate a fair value of 103.29 CZK per share.
What do the bullish and bearish scenarios say about M2C?
Our models span a range for MARK2 CORPORATION: cautious scenario 77.47 CZK, base 103.29 CZK, optimistic 129.11 CZK per share (as of Sep 24, 2026, price 127.00 CZK). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of M2C?
MARK2 CORPORATION trades at a price-to-earnings ratio of 25.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 103.29 CZK is built from several models across several years. Other multiples: P/B 0.9, P/S 0.2, EV/EBITDA 5.1.
How solid is the balance sheet of MARK2 CORPORATION (M2C)?
Balance-sheet figures for MARK2 CORPORATION (as of Sep 24, 2026): return on equity 2.8%, debt of 0.03 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is M2C from its 52-week high?
MARK2 CORPORATION trades at 127.00 CZK, about 55% below its 52-week high of 280.00 CZK and at the low of 127.00 CZK (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 103.29 CZK is for.
Which stocks are comparable to MARK2 CORPORATION?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is MARK2 CORPORATION stock attractive at the current price?
The data as of Sep 24, 2026: price 127.00 CZK, calculated fair value 103.29 CZK (−19%), Quality Score 43/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of M2C calculated?
We run MARK2 CORPORATION through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 103.29 CZK, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. MARK2 CORPORATION itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of MARK2 CORPORATION (M2C)?
The closing price on Sep 24, 2026 was 127.00 CZK. Our model-based fair value is 103.29 CZK, about −19% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with MARK2 CORPORATION right now?
Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Key figures of MARK2 CORPORATION

How large is the market capitalisation of MARK2 CORPORATION (M2C)?
The market capitalisation of MARK2 CORPORATION is 726M CZK (≈ $33.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of MARK2 CORPORATION (M2C)?
The price-to-sales ratio of MARK2 CORPORATION is 0.11 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of MARK2 CORPORATION (M2C)?
Earnings per share at MARK2 CORPORATION are 4.92 CZK (price ÷ EPS = P/E 25.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of MARK2 CORPORATION (M2C)?
The net margin of MARK2 CORPORATION is 0.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of MARK2 CORPORATION (M2C)?
The return on equity (ROE) of MARK2 CORPORATION is 2.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of MARK2 CORPORATION (M2C)?
On an EBIT basis the return on assets of MARK2 CORPORATION is 9.6% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of MARK2 CORPORATION (M2C)?
The operating margin of MARK2 CORPORATION is 1.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much free cash flow does MARK2 CORPORATION (M2C) generate?
The free cash flow of MARK2 CORPORATION is −215M CZK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch MARK2 CORPORATION in the live analysis

One click puts MARK2 CORPORATION on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.